BioSyent Inc. (TSXV:RX)

BioSyent Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.69	21.79	12.11	7.98	7.86	18.04
Short-Term Investments	3.25	6.86	3.83	18.2	20.83	10.18
Cash & Short-Term Investments	8.94	28.65	15.94	26.19	28.7	28.21
Cash Growth	-56.09%	79.74%	-39.13%	-8.74%	1.72%	10.30%
Accounts Receivable	6.02	3.73	2.39	3.45	3.18	2.49
Other Receivables	0.68	0.72	0.51	0.03	0.32	0.29
Receivables	6.77	4.54	2.99	3.55	3.66	3.21
Inventory	10.74	6.42	5.33	5.89	4.54	2.2
Prepaid Expenses	2.07	0.19	0.2	0.24	0.25	0.46
Other Current Assets	0.01	-	0.01	-	-	-
Total Current Assets	28.54	39.79	24.47	35.87	37.14	34.08
Property, Plant & Equipment	1.54	0.94	1.16	1.4	1.61	1.85
Long-Term Investments	3.29	3.29	10.1	2.5	-	-
Other Intangible Assets	22.59	4.63	4.88	1.02	1.09	0.83
Long-Term Deferred Tax Assets	0.5	0.51	0.4	0.36	0.21	0.1
Long-Term Deferred Charges	0.21	0.2	0.2	0.17	0.17	0.12
Total Assets	60.46	49.44	41.36	41.53	40.49	37.17

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.99	6.15	4	5.08	5.06	3.56
Current Portion of Leases	0.44	0.21	0.2	0.18	0.17	0.16
Current Income Taxes Payable	1.22	0.41	0.4	0.11	0.32	0.1
Current Unearned Revenue	0.3	0.42	0.81	0.13	0.16	0.31
Other Current Liabilities	3.85	0.02	-	0.03	-	-
Total Current Liabilities	13.8	7.22	5.41	5.53	5.72	4.14
Long-Term Leases	0.7	0.63	0.84	1.04	1.22	1.4
Long-Term Deferred Tax Liabilities	0.12	0.13	0.11	0.2	0.18	0.08
Total Liabilities	14.62	7.97	6.36	6.77	7.12	5.61

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8.92	5.25	5.31	5.12	5.37	5.8
Additional Paid-In Capital	1.82	2.16	2.14	2.29	2.23	1.82
Retained Earnings	35.25	34.24	27.73	27.53	25.91	24.12
Comprehensive Income & Other	-0.15	-0.18	-0.17	-0.18	-0.14	-0.19
Shareholders' Equity	45.84	41.47	35	34.76	33.36	31.55
Total Liabilities & Equity	60.46	49.44	41.36	41.53	40.49	37.17

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.14	0.84	1.04	1.22	1.4	1.56
Net Cash (Debt)	5.8	27.81	14.9	24.97	27.3	26.65
Net Cash Growth	-70.13%	86.61%	-40.31%	-8.55%	2.42%	11.67%
Net Cash Per Share	0.50	2.42	1.26	2.05	2.18	2.07
Filing Date Shares Outstanding	11.31	11.5	11.26	11.61	12.1	12.41
Total Common Shares Outstanding	11.34	11.26	11.28	11.74	12.1	12.56
Working Capital	14.74	32.58	19.07	30.34	31.42	29.94
Book Value Per Share	4.04	3.68	3.10	2.96	2.76	2.51
Tangible Book Value	19.46	36.83	30.13	33.74	32.27	30.72
Tangible Book Value Per Share	1.72	3.27	2.67	2.87	2.67	2.45
Machinery	1.29	0.99	0.95	0.91	0.85	0.81
Leasehold Improvements	0.73	0.68	0.68	0.68	0.68	0.68

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error